Saturn V Capital Management LP

Investment Portfolio & 13F Holdings Analysis

About

CIK: 0001964437

Type: FundHoldings: 21Value: $198.2MLatest: 2025Q1

Saturn V Capital Management LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 21 holdings worth $0.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "MRUS",
  "ASND",
  "CNTA",
  "NAMS",
  "ARGX",
  "ABVX",
  "SLN",
  "SNDX",
  "AMLX",
  "CTNM",
  "KALV",
  "MLTX",
  "COGT",
  "INZY",
  "XENE",
  "PCVX",
  "CELC",
  "CGON",
  "CRNX",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 21
Total Value: 198158284
Accession Number: 0001964437-25-000005
Form Type: 13F-HR
CIK: saturn-v-capital-management-lp
Manager Name: Saturn-V-Capital-Management-Lp

Data Enrichment

100% identified

21 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

21 positions • $198.2M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

Ascendis Pharma A/S

ASND|04351P101

Shares:199.3K

Value:$31.1M

% of Portfolio:15.7% ($31.1M/$198.2M)

Disc Medicine, Inc.

IRON|254604101

Shares:518.2K

Value:$25.7M

% of Portfolio:13.0% ($25.7M/$198.2M)

CG Oncology, Inc.

CGON|156944100

Shares:577.7K

Value:$14.1M

% of Portfolio:7.1% ($14.1M/$198.2M)

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:413.7K

Value:$13.9M

% of Portfolio:7.0% ($13.9M/$198.2M)

Merus N.V.

MRUS|N5749R100

Shares:323.2K

Value:$13.6M

% of Portfolio:6.9% ($13.6M/$198.2M)

MoonLake Immunotherapeutics

MLTX|61559X104

Shares:343.8K

Value:$13.4M

% of Portfolio:6.8% ($13.4M/$198.2M)

Syndax Pharmaceuticals Inc

SNDX|87164F105

Shares:1.0M

Value:$12.8M

% of Portfolio:6.5% ($12.8M/$198.2M)

Celcuity Inc.

CELC|15102K100

Shares:1.1M

Value:$11.1M

% of Portfolio:5.6% ($11.1M/$198.2M)

Cogent Biosciences, Inc.

COGT|19240Q201

Shares:1.5M

Value:$8.9M

% of Portfolio:4.5% ($8.9M/$198.2M)

Vaxcyte, Inc.

PCVX|92243G108

Shares:232.3K

Value:$8.8M

% of Portfolio:4.4% ($8.8M/$198.2M)

Amylyx Pharmaceuticals, Inc.

AMLX|03237H101

Shares:2.4M

Value:$8.6M

% of Portfolio:4.3% ($8.6M/$198.2M)

ARGENX SE

ARGX|04016X101

Shares:13.9K

Value:$8.2M

% of Portfolio:4.1% ($8.2M/$198.2M)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:448.7K

Value:$6.5M

% of Portfolio:3.3% ($6.5M/$198.2M)

OCULAR THERAPEUTIX, INC

OCUL|67576A100

Shares:598.2K

Value:$4.4M

% of Portfolio:2.2% ($4.4M/$198.2M)

Contineum Therapeutics, Inc.

CTNM|21217B100

Shares:561.0K

Value:$3.9M

% of Portfolio:2.0% ($3.9M/$198.2M)

Abivax S.A.

ABVX|00370M103

Shares:552.9K

Value:$3.5M

% of Portfolio:1.7% ($3.5M/$198.2M)

KalVista Pharmaceuticals, Inc.

KALV|483497103

Shares:255.1K

Value:$2.9M

% of Portfolio:1.5% ($2.9M/$198.2M)

NewAmsterdam Pharma Co N.V.

NAMS|N62509109

Shares:116.4K

Value:$2.4M

% of Portfolio:1.2% ($2.4M/$198.2M)

Silence Therapeutics plc

SLN|82686Q101

Shares:732.5K

Value:$2.1M

% of Portfolio:1.0% ($2.1M/$198.2M)

Crinetics Pharmaceuticals, Inc.

CRNX|22663K107

Shares:59.0K

Value:$2.0M

% of Portfolio:1.0% ($2.0M/$198.2M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Ascendis Pharma A/S(ASNDcusip04351P101)	199.3K	QoQ +0.14% (+287) YoY +92.65% (+95.8K)	All Managers (Combined)	$31.1M	15.7% ($31.1M/$198.2M)	QoQ +13.37% (+$3.7M) YoY +98.63% (+$15.4M)
Disc Medicine, Inc.(IRONcusip254604101)	518.2K	QoQ +1.72% (-8.8K) YoY +103.36% (+263.4K)	All Managers (Combined)	$25.7M	13.0% ($25.7M/$198.2M)	QoQ -20.35% (-$6.6M) YoY +62.14% (+$9.9M)
CG Oncology, Inc.(CGONcusip156944100)	577.7K	QoQ -2.62% (-15.6K) YoY NEW(+577.7K)	All Managers (Combined)	$14.1M	7.1% ($14.1M/$198.2M)	QoQ -16.84% (-$2.9M) YoY NEW(+$14.1M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	413.7K	QoQ +28.29% (+91.2K) YoY NEW(+413.7K)	All Managers (Combined)	$13.9M	7.0% ($13.9M/$198.2M)	QoQ +9.80% (+$1.2M) YoY NEW(+$13.9M)
Merus N.V.(MRUScusipN5749R100)	323.2K	QoQ +37.74% (+88.6K) YoY -14.18% (-53.4K)	All Managers (Combined)	$13.6M	6.9% ($13.6M/$198.2M)	QoQ +37.88% (+$3.7M) YoY -19.78% (-$3.4M)
MoonLake Immunotherapeutics(MLTXcusip61559X104)	343.8K	QoQ -0.65% (-2.3K) YoY NEW(+343.8K)	All Managers (Combined)	$13.4M	6.8% ($13.4M/$198.2M)	QoQ -28.32% (-$5.3M) YoY NEW(+$13.4M)
Syndax Pharmaceuticals Inc(SNDXcusip87164F105)	1.0M	QoQ +5.33% (-52.8K) YoY +161.63% (+643.3K)	All Managers (Combined)	$12.8M	6.5% ($12.8M/$198.2M)	QoQ -2.11% (-$276.2K) YoY +35.04% (+$3.3M)
Celcuity Inc.(CELCcusip15102K100)	1.1M	QoQ +2.81% (-29.9K) YoY NEW(+1.1M)	All Managers (Combined)	$11.1M	5.6% ($11.1M/$198.2M)	QoQ -20.59% (-$2.9M) YoY NEW(+$11.1M)
Cogent Biosciences, Inc.(COGTcusip19240Q201)	1.5M	QoQ -1.22% (-18.4K) YoY -7.20% (-115.0K)	All Managers (Combined)	$8.9M	4.5% ($8.9M/$198.2M)	QoQ -24.14% (-$2.8M) YoY -17.28% (-$1.9M)
Vaxcyte, Inc.(PCVXcusip92243G108)	232.3K	QoQ +13.71% (-28.0K) YoY +25.44% (-47.1K)	All Managers (Combined)	$8.8M	4.4% ($8.8M/$198.2M)	QoQ -47.54% (-$8.0M) YoY -30.65% (-$3.9M)
Amylyx Pharmaceuticals, Inc.(AMLXcusip03237H101)	2.4M	QoQ +172.91% (+1.5M) YoY NEW(+2.4M)	All Managers (Combined)	$8.6M	4.3% ($8.6M/$198.2M)	QoQ +155.58% (+$5.2M) YoY NEW(+$8.6M)
ARGENX SE(ARGXcusip04016X101)	13.9K	QoQ -29.82% (-5.9K) YoY -78.86% (-51.7K)	All Managers (Combined)	$8.2M	4.1% ($8.2M/$198.2M)	QoQ -32.46% (-$3.9M) YoY -68.23% (-$17.6M)
Centessa Pharmaceuticals plc(CNTAcusip152309100)	448.7K	QoQ NEW(+448.7K) YoY NEW(+448.7K)	All Managers (Combined)	$6.5M	3.3% ($6.5M/$198.2M)	QoQ NEW(+$6.5M) YoY NEW(+$6.5M)
OCULAR THERAPEUTIX, INC(OCULcusip67576A100)	598.2K	QoQ +212.44% (+406.7K) YoY NEW(+598.2K)	All Managers (Combined)	$4.4M	2.2% ($4.4M/$198.2M)	QoQ +168.17% (+$2.7M) YoY NEW(+$4.4M)
Contineum Therapeutics, Inc.(CTNMcusip21217B100)	561.0K	QoQ -2.10% (-12.0K) YoY NEW(+561.0K)	All Managers (Combined)	$3.9M	2.0% ($3.9M/$198.2M)	QoQ -53.35% (-$4.5M) YoY NEW(+$3.9M)
Abivax S.A.(ABVXcusip00370M103)	552.9K	QoQ -15.33% (-100.1K) YoY -11.24% (-70.0K)	All Managers (Combined)	$3.5M	1.7% ($3.5M/$198.2M)	QoQ -27.71% (-$1.3M) YoY -61.20% (-$5.5M)
KalVista Pharmaceuticals, Inc.(KALVcusip483497103)	255.1K	QoQ -54.16% (-301.4K) YoY -82.31% (-1.2M)	All Managers (Combined)	$2.9M	1.5% ($2.9M/$198.2M)	QoQ -37.55% (-$1.8M) YoY -82.78% (-$14.2M)
NewAmsterdam Pharma Co N.V.(NAMScusipN62509109)	116.4K	QoQ +16.35% (-16.4K) YoY NEW(+116.4K)	All Managers (Combined)	$2.4M	1.2% ($2.4M/$198.2M)	QoQ -7.32% (-$188.3K) YoY NEW(+$2.4M)
Silence Therapeutics plc(SLNcusip82686Q101)	732.5K	QoQ +85.42% (-337.4K) YoY NEW(+732.5K)	All Managers (Combined)	$2.1M	1.0% ($2.1M/$198.2M)	QoQ -23.99% (-$652.2K) YoY NEW(+$2.1M)
Crinetics Pharmaceuticals, Inc.(CRNXcusip22663K107)	59.0K	QoQ -0.18% (-108) YoY -91.05% (-601.1K)	All Managers (Combined)	$2.0M	1.0% ($2.0M/$198.2M)	QoQ -34.52% (-$1.0M) YoY -93.59% (-$28.9M)